Walleye Capital
BMRN icon

Walleye Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History

Walleye Capital’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$350K Sell
6,200
-2,000
-24% -$117K ﹤0.01% 2944
2025
Q4 		$487K Buy
8,200
+4,900
+148% +$267K ﹤0.01% 2978
2025
Q3 		$179K Sell
3,300
-1,200
-27% -$68.6K ﹤0.01% 3387
2025
Q2 		$247K Sell
4,500
-19,200
-81% -$1.13M ﹤0.01% 3201
2025
Q1 		$1.68M Sell
23,700
-1,500
-6% -$101K 0.01% 1548
2024
Q4 		$1.66M Buy
25,200
+1,300
+5% +$87.1K ﹤0.01% 1957
2024
Q3 		$1.68M Buy
23,900
+3,300
+16% +$276K ﹤0.01% 2128
2024
Q2 		$1.7M Buy
20,600
+10,900
+112% +$907K ﹤0.01% 2264
2024
Q1 		$847K Sell
9,700
-13,600
-58% -$1.22M ﹤0.01% 2749
2023
Q4 		$2.25M Buy
23,300
+3,900
+20% +$345K ﹤0.01% 1691
2023
Q3 		$1.72M Buy
19,400
+10,700
+123% +$952K ﹤0.01% 1847
2023
Q2 		$754K Sell
8,700
-10,700
-55% -$1.01M ﹤0.01% 2088
2023
Q1 		$1.89M Buy
19,400
+15,200
+362% +$1.58M 0.03% 760
2022
Q4 		$435K Buy
+4,200
New +$394K 0.01% 1543
2020
Q1 		– Sell
-500
Closed -$42K – 968
2019
Q4 		$42K Sell
500
-15,000
-97% -$1.13M ﹤0.01% 1531
2019
Q3 		$1.04M Buy
+15,500
New +$1.19M 0.06% 431
2019
Q2 		– Sell
-4,900
Closed -$435K – 1740
2019
Q1 		$435K Buy
+4,900
New +$454K 0.07% 436

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's BMRN Position: Q1 2026 in Review

Walleye Capital increased its BioMarin Pharmaceuticals (BMRN) stake by 64% in Q1 2026, buying an estimated $8.27M and bringing the position to 364,246 shares worth $20.6M. The position accounts for 0.09% of the portfolio, ranked #188.

Walleye Capital first reported a position in BMRN in Q1 2019 and has held it in 20 quarters since. 554 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.

  • Walleye Capital held 364,246 shares of BioMarin Pharmaceuticals worth $20.6M as of Q1 2026.
  • Walleye Capital bought 141,779 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $8.27M.
  • BioMarin Pharmaceuticals made up 0.09% of Walleye Capital's portfolio in Q1 2026, its #188 holding.
  • Walleye Capital first reported a position in BioMarin Pharmaceuticals in Q1 2019 and has held it in 20 quarters since.
  • 554 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.